Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AACR 2023
Pharma
AACR: AstraZeneca's Imfinzi fuels key debate in resectable NSCLC
Imfinzi's resectable lung cancer data left several questions unanswered about the neoadjuvant-plus-adjuvant treatment proposal.
Angus Liu
Apr 16, 2023 11:00am
Patient deaths taint Roche's landmark adjuvant liver cancer data
Apr 16, 2023 11:00am
AACR: Merck clashes with AstraZeneca in biliary tract cancer
Apr 16, 2023 11:00am
